Publication | Closed Access

One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration

Ocular DiseaseVitreous BodyOphthalmologyOne-year ResultsGlaucomaIntravitreal FaricimabMedicineTreat-and-extend Regimen